Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Trinity Biotech plc to Host Investor Call
By: GlobeNewswire - 30 Jan 2024Back to overview list

Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET

DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations.

Conference Call Dial-In & Webcast Information

Date:Wednesday, January 31, 2024
Time:8:30 AM ET
United States:1-877-407-0784
International:1-201-689-8560
Conference ID:13744109
Webcast:Click Here for Webcast
CallMe™:Click Here for CallMe Feature


About Trinity Biotech

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com.

Contact:Trinity Biotech plc
Des Fitzgerald
(353)-1-2769800
LifeSci Partners, LLC
Eric Ribner
(1)-646-751-4363
E-mail investorrelations@trinitybiotech.com


Related companies:Trinity Biotech Plc
Copyright 2024 GlobeNewswire Back to overview list
to the top ↑